SIGA
SIGA Technologies, Inc.
$4.68
-0.03
(-0.64%)
Mkt Cap
335.67M
Volume
598,409
52W Range
4.1-9.62
Sector
Healthcare
Beta
0.85
EPS (TTM)
0.29
P/E Ratio
16.34
Revenue (TTM)
93.78M
Rev Growth (5Y)
-5.4%
EPS Growth (5Y)
-14.2%
AlphaVal · Fair Value
$22.14
Undervalued · Strong
78.9% below fair value
AlphaQuality · Grade
B-
Platform & Compounding FCF
64.8 / 100 composite
Company Description
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.
Track Record
Showing latest 4 periods • Swipe for more
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 94.60M | 138.72M | 139.92M | 110.78M | 133.67M | 124.96M | 26.74M | 477.05M | 12.27M | 14.99M | 8.18M | 3.14M |
| Net Income | 23.30M | 59.21M | 68.07M | 33.90M | 69.45M | 56.34M | (7.24M) | 421.81M | (36.24M) | (39.70M) | (39.45M) | (265.46M) |
| EPS | 0.33 | 0.83 | 0.95 | 0.46 | 0.92 | 0.71 | -0.09 | 5.28 | -0.46 | -0.69 | -0.73 | -4.97 |
| Free Cash Flow | 43.12M | 48.72M | 94.78M | 41.61M | 11.44M | 71.50M | (18.23M) | 68.77M | (8.26M) | (115.61M) | N/A | N/A |
| FCF / Share | 0.60 | 0.68 | 1.33 | 0.57 | 0.15 | 0.90 | -0.23 | 0.86 | -0.10 | -2.02 | N/A | N/A |
| Operating CF | 43.47M | 48.76M | 94.80M | 41.61M | 11.49M | 71.52M | (18.20M) | 68.87M | (8.16M) | (115.59M) | N/A | N/A |
| Total Assets | 219.47M | 244.34M | 254.35M | 195.04M | 214.73M | 149.83M | 198.57M | 203.44M | 144.67M | 160.98M | N/A | N/A |
| Total Debt | 595,169 | 546,820 | 564,009 | 528,170 | 466,830 | 449,940 | 80.46M | 75.55M | 71.05M | 66.55M | N/A | N/A |
| Cash & Equiv | 154.97M | 155.40M | 150.15M | 98.79M | 103.14M | 117.89M | 65.25M | 100.65M | 19.86M | 28.70M | N/A | N/A |
| Book Value | 198.82M | 215.80M | 196.86M | 170.16M | 174.31M | 129.79M | 97.78M | 102.91M | (323.14M) | (287.42M) | N/A | N/A |
| Return on Equity | 0.12 | 0.27 | 0.35 | 0.20 | 0.40 | 0.43 | -0.07 | 4.10 | N/A | N/A | N/A | N/A |
| Metric | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.24M | 3.80M | 2.62M | 81.12M | 7.04M | 81.47M | 10.01M | 21.81M | 25.43M | 116.48M | 9.24M | 5.88M |
| Net Income | (3.45M) | (5.40M) | (6.37M) | 35.48M | (408,223) | 45.76M | 1.34M | 1.83M | 10.28M | 72.26M | (393,066) | (2.88M) |
| EPS | -0.05 | -0.08 | -0.09 | 0.50 | -0.01 | 0.64 | 0.02 | 0.03 | 0.14 | 1.02 | -0.01 | -0.04 |
| Free Cash Flow | (8.66M) | (16.90M) | (10.10M) | 63.08M | 7.04M | 56.29M | (7.41M) | 5.95M | (6.12M) | 79.03M | (5.10M) | (3.60M) |
| FCF / Share | -0.12 | -0.24 | -0.14 | 0.88 | 0.10 | 0.79 | -0.10 | 0.08 | -0.09 | 1.11 | -0.07 | -0.05 |
| Operating CF | (8.66M) | (16.86M) | (9.81M) | 63.08M | 7.06M | 56.31M | (7.38M) | 5.95M | (6.12M) | 79.03M | (5.10M) | (3.58M) |
| Total Assets | 219.39M | 219.47M | 231.60M | 235.33M | 247.07M | 244.34M | 195.35M | 192.66M | 243.15M | 254.35M | 158.38M | 146.51M |
| Total Debt | 638,231 | 595,169 | 914,548 | 570,426 | 558,651 | 546,820 | 535,234 | 523,889 | 503,470 | 564,009 | 554,732 | 545,558 |
| Cash & Equiv | 145.56M | 154.97M | 171.96M | 182.46M | 162.27M | 155.40M | 99.27M | 106.95M | 143.87M | 150.15M | 71.11M | 76.21M |
| Book Value | 151.62M | 198.82M | 203.48M | 209.31M | 216.13M | 215.80M | 169.44M | 167.56M | 164.99M | 196.86M | 124.14M | 124.07M |
| Return on Equity | -0.02 | -0.03 | -0.03 | 0.17 | -0.00 | 0.21 | 0.01 | 0.01 | 0.06 | 0.37 | -0.00 | -0.02 |
SIGA News
Siga Technologies Q1 Earnings Call Highlights
SIGA Technologies, Inc. (SIGA) Q1 2026 Earnings Call Transcript
SIGA Reports Financial Results for Three Months Ended March 31, 2026 and Provides Business Update
SIGA to Host Business Update Call on May 7, 2026, Following Release of First-Quarter 2026 Financial Results
JPMorgan Chase & Co. Increases Stake in Siga Technologies Inc. $SIGA
Siga Technologies Sees Unusually High Options Volume (NASDAQ:SIGA)
Siga Technologies (NASDAQ:SIGA) and CASI Pharmaceuticals (NASDAQ:CASI) Financial Comparison
Why Are Siga Technologies Shares Trading Higher?
SIGA Declares Special Cash Dividend of $0.60 Per Share
EOM Pharmaceutical (OTCMKTS:IMUC) & Siga Technologies (NASDAQ:SIGA) Financial Survey